ARIPRA aripiprazole 15mg tablet blister pack

Country: Аустралија

Језик: Енглески

Извор: Department of Health (Therapeutic Goods Administration)

Активни састојак:

aripiprazole, Quantity: 15 mg

Доступно од:

Medis Pharma Pty Ltd

INN (Међународно име):

aripiprazole

Фармацеутски облик:

Tablet, uncoated

Састав:

Excipient Ingredients: microcrystalline cellulose; lactose monohydrate; hyprolose; maize starch; magnesium stearate

Пут администрације:

Oral

Јединице у пакету:

30

Тип рецептора:

(S4) Prescription Only Medicine

Терапеутске индикације:

Aripiprazole is indicated for the treatment of schizophrenia including maintenance of clinical improvement during continuation therapy.,Acute treatment of manic or mixed episodes associated with Bipolar I Disorder in adults as monotherapy and in combination with lithium or valproate;,Maintenance treatment of manic or mixed episodes in Bipolar I Disorder in adults as monotherapy.

Резиме производа:

Visual Identification: 7mm, round, biconvex, white uncoated tablets with 15 debossed on one side and ZL on the other side; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Статус ауторизације:

Licence status A

Датум одобрења:

2014-10-29